UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000031240
Receipt No. R000035463
Official scientific title of the study Evaluation of clinical efficacy and safety of sentinel lymph node biopsy using magnetic nanoparticle and magnetic probe
Date of disclosure of the study information 2018/02/09
Last modified on 2018/02/09 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of clinical efficacy and safety of sentinel lymph node biopsy using magnetic nanoparticle and magnetic probe
Title of the study (Brief title) Evaluation of clinical efficacy and safety of sentinel lymph node biopsy using magnetic nanoparticle and magnetic probe
Region
Japan

Condition
Condition Breast cancer
Classification by specialty
Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is, using super paramagnetic iron oxide (SPIO)/magnetic probe system model, to demonstrate non-inferiority of SPIO/magnetic probe system compared with an isotope technique for SNB in patients with breast cancer.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Identification rate
Key secondary outcomes Safety

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification NO
Dynamic allocation
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 On the day before surgery or in the morning of the operation day, 1ml a superparamagnetic iron oxide (SPIO) contrast agent are injected on the same side of breast cancer in subcutaneous areola. All sentinel lymph nodes detected intraoperatively by using the magnetic probe system model or gamma probe or nodes that were blue or brown, were excised. Sentinel lymph nodes are evaluated the status of node metastasis and iron-staining.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Primary breast cancer with clinical no lymph node metastasis
Key exclusion criteria 1. Breast cancer recurrence
2. Who had a history of operation of Axilla
3. Post operative status of augmentation mammaplasty
4. Male breast cancer
Target sample size 180

Research contact person
Name of lead principal investigator Hiroyuki Takei
Organization Nippon Medical School Hospital
Division name Department of Breast Surgery
Address 1-1-5 Sendagi, Bunkyo-ku, Tokyo
TEL 03-3822-2131
Email takei-hiroyuki@nms.ac.jp

Public contact
Name of contact person Tomoko Kurita
Organization Nippon Medical School Hospital
Division name Department of Breast Surgery
Address 1-1-5 Sendagi, Bunkyo-ku, Tokyo
TEL 03-3822-2131
Homepage URL
Email tomoko28@nms.ac.jp

Sponsor
Institute Japan Agency for Medical Research and Development
Institute
Department

Funding Source
Organization Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor Nippon Medical School
Showa University
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 日本医科大学(東京都)、昭和大学(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 09 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 10 Month 18 Day
Anticipated trial start date
2016 Year 10 Month 18 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 02 Month 09 Day
Last modified on
2018 Year 02 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035463